Japanese drugmaker Shionogi (TYO: 4507) is to scale up its pipeline and global ambitions with a deal worth more than $1 ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Tepezza (teprotumumab (Tepezza). This ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Israel’s Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today reported results for the quarter ended March 31, 2025.

UK-based pharma major AstraZeneca and its Japanese partner Daiichi Sankyo are moving to expand the reach of their blockbuster ...

US President Donald Trump has signed an executive order attempting to restore a robust domestic manufacturing base for ...

Sino American biotech BeiGene (Nasdaq: ONC; HKEX: 06160), a global oncology company that will change its name to BeOne ...

French drugmaker Ipsen (Euronext: IPN) today announced new data from two late-breaking presentations on Iqirvo (elafibranor) ...

Shares in Danish drugmaker Novo Nordisk were 3% higher on Wednesday afternoon after the company presented its first-quarter ...

NewLimit was founded to develop medicines that add healthy years to each human life. Initially, we thought it would take many ...

Lossmaking Danish pharma ingredients maker Xellia Pharmaceuticals said it could only survive against Chinese competition by ...

California-based Atara Biotherapeutics (Nasdaq: ATRA) revealed that the US Food and Drug Administration (FDA) has lifted the ...